Aveeno ‘Baby’ Product Overpayment Claims Viable, but Dismissed

An Aveeno product purchaser raised potentially viable claims that Johnson & Johnson Consumer Inc. dupes consumers into thinking “baby” products are uniquely formulated for babies, but she didn’t show she had suffered financial harm.

Bonny Schippell didn’t offer factual support showing she had overpaid, the US District Court for the Central District of California said, dismissing her proposed class action.

But the pleading deficiencies “likely” can be cured with additional facts, it said in an order entered Wednesday.

Schippell alleged that “Aveeno Baby Continuous Protection Sensitive Skin Lotion Zinc Oxide Sunscreen” and “Aveeno Baby Eczema Therapy Moisturizing Cream” are identical ...